サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1788368

遠隔てんかんの世界市場

Tele-Epilepsy

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
遠隔てんかんの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

遠隔てんかんの世界市場は2030年までに13億米ドルに達する見込み

2024年に5億1,860万米ドルと推定される遠隔てんかんの世界市場は、2024～2030年の分析期間においてCAGR 16.3％で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つである小児科は、CAGR14.8%を記録し、分析期間終了時には7億6,380万米ドルに達すると予測されています。成人セグメントの成長率は、分析期間でCAGR 18.9％と推定されます。

米国市場は1億3,630万米ドルと推定、中国はCAGR15.5％で成長予測

米国の遠隔てんかん市場は、2024年に1億3,630万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億9,930万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは15.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ14.8%と14.3%と予測されています。欧州では、ドイツがCAGR約12.1%で成長すると予測されています。

世界の遠隔てんかん市場- 主要動向と促進要因まとめ

遠隔神経学はてんかん管理改革の鍵となるか？

遠隔てんかんは、多様な集団におけるてんかんの診断と管理のために、非常に効率的でスケーラブルなモデルを導入し、神経学的ケアの展望を急速に変えています。従来、てんかん治療は、神経内科医やてんかん専門医の数が限られているため、都市部の医療センターに集中しており、地方や十分なサービスを受けていない地域では、専門的なサービスへのアクセスが不十分でした。遠隔てんかんは、バーチャルプラットフォームを通じてリアルタイムの診察、ビデオ脳波解釈、投薬管理を可能にすることで、この長年のギャップに対処します。遠隔てんかんは、移動が困難な患者や三次医療センターから遠く離れた場所に住む患者にとって特に有益であり、ケアの継続性を維持する上で極めて重要であることが証明されています。安全なビデオ会議技術、デジタル発作日誌、クラウド統合型脳波モニタリングシステムの台頭により、患者のエンゲージメントと臨床結果が向上しています。さらに、主要な神経医療機関では、多くの国で政策レベルの承認と償還規定に支えられ、遠隔てんかんを標準治療プロトコルに組み込んでいます。小児てんかんの管理は、遠隔での親のコーチングやバーチャルな発達評価によって顕著な改善が見られています。さらに、ウェアラブル発作検出装置から遠隔医療チャンネルを通じて神経科医にリアルタイムでデータが送信されることで、より正確な診断と個別の治療計画が可能になりました。世界のヘルスケアエコシステムのデジタル化が進む中、遠隔てんかんは、てんかんへのアクセスを平等にし、てんかん関連の合併症の負担を軽減する可能性を秘めた、将来を見据えた現実的なソリューションとして注目されています。

患者や介護者は、てんかん治療のデジタルシフトをどのように推進しているのでしょうか？

遠隔てんかん市場の成長の大きなきっかけとなったのは、デジタルヘルスケアソリューションに対する患者や介護者の意識の変化です。てんかんは慢性的な神経疾患であり、頻繁なモニタリングと微妙な管理が必要なため、家族や個人はその利便性と柔軟性から遠隔医療をますます受け入れるようになっています。現代の消費者、特に若い患者や技術に精通した介護者は、定期的な経過観察、投薬の調整、ライフスタイルのカウンセリングなど、遠隔診療の手軽さを好んでいます。また、いくつかの文化圏では、てんかんにまつわるスティグマ（烙印）があるため、バーチャルケアは魅力的な選択肢となっており、患者は対面診療の社会的プレッシャーを感じることなく専門家の指導を受けることができます。このような行動の変化は、リアルタイムの発作記録、自動服薬リマインダー、個別化されたアラートを可能にするユーザーフレンドリーなプラットフォームが利用可能になったことでさらに強化されています。患者は現在、発作パターンや投薬効果を追跡するのに役立つAI主導の分析機能を統合したモバイルアプリケーションを利用できるようになり、バーチャル診察の際に神経科医と簡単に共有できるツールとなっています。さらに、サポートグループや地域の健康プログラムでは、遠隔てんかんプラットフォームを活用して、バーチャルグループカウンセリングや仲間同士の交流を促進し、精神的なサポートネットワークを強化しています。学校や職場でも、生徒や従業員が遠隔神経サポートシステムを利用できるように対応し、日常生活で遠隔てんかんソリューションを利用することが当たり前になってきています。遠隔てんかんは、長期的な神経学的健康管理に必要不可欠であり、信頼され、好まれているのです。

最先端技術がてんかんの治療法を変える？

新たなテクノロジーは、遠隔てんかんの能力と到達範囲に革命をもたらし、診断、治療、患者モニタリングの従来のパラダイムを再定義しています。高度なクラウド・コンピューティングによって実現された高解像度の遠隔脳波解釈システムにより、神経科医は脳波パターンを分析し、遠隔地であっても臨床的な精度でてんかん活動を検出することができます。機械学習アルゴリズムは、発作の誘因を特定し発作エピソードを予測するために、発作イベントの大規模なデータセットで訓練されており、リアルタイムの予測医療を具体的なものにしています。電気活動、心拍変動、動きをモニターするリストバンドやヘッドバンドなどのウェアラブル・バイオセンサーとの統合により、自宅での継続的モニタリングの領域が広がっています。これらのデータストリームは専門医に安全に送信され、迅速に分析されるため、診断の遅れが減少し、積極的な治療の修正が可能になります。農村部や遠隔地では、神経診断ツールと衛星接続を備えた移動式遠隔医療ユニットが、以前は手の届かなかった地域に専門家によるてんかん治療をもたらしています。さらに、クラウドベースのプラットフォームが非同期ケアを可能にし、患者は発作のビデオをアップロードし、リアルタイムでのやり取りを必要とせずに専門家のレビューを受けることができます。拡張現実（AR）ツールは、緊急発作介入プロトコルの介護者や救急隊員のトレーニング用に試験的に導入されており、遠隔てんかんサービスに重要な教育的要素を加えています。ブロックチェーンに対応した医療記録と電子処方箋システムは、安全で追跡可能な治療履歴を保証します。このような強固な技術的サポートにより、遠隔てんかんは、従来の対面式神経科診察に匹敵し、場合によってはそれを凌駕する包括的なケア・エコシステムへと急速に進化しています。

遠隔てんかん市場の成長加速の原動力は？

遠隔てんかん市場の成長は、先進技術の統合、患者行動の変化、ケア提供モデルの進化、施設導入の増加に関連するいくつかの要因によって牽引されています。主要な促進要因は、てんかんの世界の負担の増加であり、世界中で5,000万人以上が罹患しています。遠隔てんかんの拡張性は、このケアギャップを解決する理想的なソリューションとなります。AIを搭載した診断ツール、ウェアラブル発作検知器、クラウドベースの脳波システムなどの技術的進歩により、より迅速で正確な、分散型のてんかん管理が可能になっています。北米、欧州の一部、アジア太平洋地域では、規制当局の支援や保険償還の枠組みに遠隔てんかんが組み込まれたことで、導入が大幅に加速しています。学校、軍事施設、刑務所、高齢者介護施設など、神経学の専門家が常駐していない施設での使用が拡大し、市場成長の新たな道が開かれました。一方、患者やヘルスケアプロバイダーのデジタルリテラシーの向上は、遠隔てんかんサービスが発展するための環境を促進しています。医療機関や民間の神経科医は、遠隔てんかんをハイブリッドケアモデルに統合し、臨床の質を維持しながら業務効率を最適化する動きが加速しています。国境を越えたバーチャル診察も、特に医療ツーリズムの文脈で増加傾向にあり、患者は地理的な制約を受けることなく、一流のてんかん専門医にアクセスすることができます。データ相互運用性の標準化とサイバーセキュリティの向上により、ユーザーの信頼はさらに強化され、デジタルプラットフォーム間で機密性の高い医療データを安全かつシームレスに交換できるようになっています。このような多様で連動した促進要因により、遠隔てんかん市場は今後数年間、持続的でインパクトのある拡大が見込まれます。

セグメント

患者（小児、成人）;コンポーネント（ソフトウェア、ハードウェア、サービス）;エンドユーザー（病院プロバイダー、支払者、ヘルスケア消費者）

調査対象企業の例

  • Abbott Laboratories
  • Advanced Telemed Services
  • American Well Corporation（Amwell）
  • BioSerenity
  • Boston Scientific Corporation
  • Ceribell, Inc.
  • Chiron Health
  • Compumedics Limited
  • Eagle Telemedicine
  • Empatica Inc.
  • Epitel, Inc.
  • Fisher & Paykel Healthcare
  • GE Healthcare
  • Invitae Corp.
  • LivaNova PLC
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroPace Inc.
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Qynapse
  • Real Time Tele-Epilepsy Consultants（RTTC）

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33132

Global Tele-Epilepsy Market to Reach US$1.3 Billion by 2030

The global market for Tele-Epilepsy estimated at US$518.6 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 16.3% over the analysis period 2024-2030. Pediatric, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$763.8 Million by the end of the analysis period. Growth in the Adult segment is estimated at 18.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$136.3 Million While China is Forecast to Grow at 15.5% CAGR

The Tele-Epilepsy market in the U.S. is estimated at US$136.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$199.3 Million by the year 2030 trailing a CAGR of 15.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.8% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.1% CAGR.

Global Tele-epilepsy Market - Key Trends & Drivers Summarized

Can Remote Neurology Be the Key to Epilepsy Management Reform?

Tele-epilepsy is rapidly transforming the landscape of neurological care, introducing a highly efficient, scalable model for diagnosing and managing epilepsy across diverse populations. Traditionally, epilepsy care has been concentrated in urban medical centers due to the limited number of neurologists and epileptologists, leaving rural and underserved communities with inadequate access to specialized services. Tele-epilepsy addresses this long-standing gap by enabling real-time consultations, video EEG interpretations, and medication management through virtual platforms. Particularly beneficial for patients with mobility challenges or those residing far from tertiary care centers, tele-epilepsy has proved crucial in sustaining continuity of care. The rise of secure video conferencing technologies, digital seizure diaries, and cloud-integrated EEG monitoring systems has enhanced patient engagement and clinical outcomes. Moreover, leading neurological institutions are incorporating tele-epilepsy into their standard care protocols, supported by policy-level recognition and reimbursement provisions in many countries. Pediatric epilepsy management has seen notable improvements through remote parental coaching and virtual developmental assessments. Additionally, real-time data transmission from wearable seizure detection devices to neurologists via telehealth channels has empowered more accurate diagnostics and individualized treatment plans. As the global healthcare ecosystem continues to digitize, tele-epilepsy stands out as a viable, future-facing solution with the potential to equalize access and reduce the burden of epilepsy-related complications.

How Are Patients and Caregivers Driving a Digital Shift in Epilepsy Care?

A significant catalyst for the tele-epilepsy market’s growth is the shifting attitude of patients and caregivers toward digital healthcare solutions. With epilepsy being a chronic neurological condition that requires frequent monitoring and nuanced management, families and individuals are increasingly embracing telehealth for its convenience and flexibility. Modern consumers, particularly younger patients and tech-savvy caregivers, prefer the ease of remote consultations for routine follow-ups, medication adjustments, and lifestyle counseling. The stigma associated with epilepsy in several cultures has also made virtual care an attractive option, allowing patients to seek expert guidance without the social pressure of in-person visits. This behavioral shift is further reinforced by the availability of user-friendly platforms that allow real-time seizure logging, automated medication reminders, and personalized alerts. Patients now have access to mobile applications integrated with AI-driven analytics that help track seizure patterns and medication efficacy-tools which they can easily share with neurologists during virtual consultations. In addition, support groups and community health programs are now leveraging tele-epilepsy platforms to facilitate virtual group counseling and peer interactions, enhancing emotional support networks. Schools and workplaces are also adapting to accommodate students and employees using remote neurological support systems, normalizing the use of tele-epilepsy solutions in everyday life. The increasing comfort and familiarity with digital health services have positioned tele-epilepsy as an essential, trusted, and even preferred mode of managing long-term neurological health.

Could Cutting-Edge Technologies Be Reshaping the Way Epilepsy Is Treated?

Emerging technologies are revolutionizing the capabilities and reach of tele-epilepsy, redefining traditional paradigms of diagnosis, treatment, and patient monitoring. High-resolution remote EEG interpretation systems, enabled by advanced cloud computing, allow neurologists to analyze brainwave patterns and detect epileptic activity with clinical precision-even at a distance. Machine learning algorithms are being trained on large datasets of seizure events to identify triggers and forecast seizure episodes, making real-time predictive care a tangible reality. Integration with wearable biosensors-such as wristbands and headbands that monitor electrical activity, heart rate variability, and movement-has expanded the realm of at-home, continuous monitoring. These data streams are securely transmitted to specialists for rapid analysis, reducing diagnostic delays and enabling proactive treatment modifications. In rural and remote areas, mobile telemedicine units equipped with neurodiagnostic tools and satellite connectivity are bringing expert epilepsy care to communities previously beyond reach. Additionally, cloud-based platforms are enabling asynchronous care, where patients can upload videos of seizure events and receive expert reviews without needing real-time interaction. Augmented reality tools are being piloted for training caregivers and first responders in emergency seizure intervention protocols, adding a critical educational component to tele-epilepsy services. Blockchain-enabled health records and e-prescription systems ensure secure, traceable treatment histories, particularly vital for patients navigating complex, long-term care plans. With such robust technological support, tele-epilepsy is rapidly evolving into a comprehensive care ecosystem that rivals, and in some cases surpasses, traditional in-person neurology consultations.

What Forces Are Powering the Tele-Epilepsy Market’s Accelerated Growth?

The growth in the tele-epilepsy market is driven by several factors related to advanced technology integration, shifting patient behaviors, evolving care delivery models, and increased institutional adoption. A key growth driver is the increasing global burden of epilepsy, with over 50 million people affected worldwide, most of whom reside in low-resource settings where neurologist availability is minimal. The scalability of tele-epilepsy makes it an ideal solution to address this care gap. Technological advancements such as AI-powered diagnostic tools, wearable seizure detectors, and cloud-based EEG systems are enabling faster, more accurate, and decentralized epilepsy management. Regulatory support and the inclusion of tele-epilepsy in insurance reimbursement frameworks across North America, parts of Europe, and Asia-Pacific are significantly accelerating adoption. End-use expansion into schools, military facilities, prisons, and aged care homes-where on-site neurology expertise is often lacking-has opened up new avenues for market growth. Meanwhile, increased digital literacy among both patients and healthcare providers is fostering a conducive environment for tele-epilepsy services to flourish. Medical institutions and private neurologists are increasingly integrating tele-epilepsy into hybrid care models, optimizing operational efficiency while maintaining clinical quality. Cross-border virtual consultations are also on the rise, particularly in medical tourism contexts, allowing patients to access top-tier epileptologists without geographic constraints. Data interoperability standards and improvements in cybersecurity have further reinforced user confidence, enabling the safe and seamless exchange of sensitive health data across digital platforms. With these diverse and interlocking drivers, the tele-epilepsy market is poised for sustained, high-impact expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Tele-Epilepsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Patient (Pediatric, Adult); Component (Software, Hardware, Services); End-Use (Hospitals providers, Payers, Healthcare consumers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Advanced Telemed Services
  • American Well Corporation (Amwell)
  • BioSerenity
  • Boston Scientific Corporation
  • Ceribell, Inc.
  • Chiron Health
  • Compumedics Limited
  • Eagle Telemedicine
  • Empatica Inc.
  • Epitel, Inc.
  • Fisher & Paykel Healthcare
  • GE Healthcare
  • Invitae Corp.
  • LivaNova PLC
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroPace Inc.
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Qynapse
  • Real Time Tele-Epilepsy Consultants (RTTC)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tele-Epilepsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Shortage of Neurologists in Rural Areas Spurs Growth of Remote Epilepsy Consultations
    • Tele-neurology Integration Throws the Spotlight on Virtual Seizure Management Platforms
    • Rising Demand for Continuous Monitoring Accelerates Adoption of Remote EEG Solutions
    • Increasing Patient Comfort with Digital Health Drives Confidence in Tele-epilepsy Care
    • Use of Wearable Devices and AI Diagnostics Propels Growth in Real-Time Seizure Detection
    • Expanding Internet and Smartphone Access in Emerging Markets Broadens Reach of Tele-epilepsy
    • Post-COVID Normalization of Telehealth Visits Sustains Growth in Virtual Neurology Services
    • Remote Care Needs in Pediatrics and Geriatrics Drive Penetration of Epilepsy Teleconsultations
    • Cross-Border Specialist Access Expands Addressable Market for Complex Epilepsy Cases
    • Integration with EHR Systems and Remote Patient Monitoring Tools Drives Clinical Adoption
    • Growing Mental Health Comorbidities in Epilepsy Care Throws Spotlight on Virtual Counseling Integration
    • School, Military, and Correctional Health Settings Generate Demand for Scalable Tele-epilepsy Solutions
    • Healthcare Cost Pressures and Need for Early Intervention Propel Growth of Virtual Epilepsy Triage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tele-Epilepsy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tele-Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Tele-Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospitals providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Healthcare consumers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Healthcare consumers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • JAPAN
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • CHINA
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • EUROPE
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Tele-Epilepsy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Tele-Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • FRANCE
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • GERMANY
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • UNITED KINGDOM
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Tele-Epilepsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Tele-Epilepsy by Patient - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Tele-Epilepsy by Patient - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Tele-Epilepsy by Component - Software, Hardware and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Tele-Epilepsy by Component - Percentage Breakdown of Value Sales for Software, Hardware and Services for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Tele-Epilepsy by End-Use - Hospitals providers, Payers and Healthcare consumers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Tele-Epilepsy by End-Use - Percentage Breakdown of Value Sales for Hospitals providers, Payers and Healthcare consumers for the Years 2025 & 2030

IV. COMPETITION